Halozyme Therapeutics, Inc. (HALO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 38.02 |
| Open | 37.95 |
| Bid | 37.78 x 800 |
| Ask | 37.85 x 400 |
| Day's range | 37.73 - 38.41 |
| 52-week range | 29.85 - 45.00 |
| Volume | |
| Avg. volume | 1,079,979 |
| Market cap | 4.804B |
| Beta (5Y monthly) | 1.25 |
| PE ratio (TTM) | 18.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Halozyme Therapeutics (HALO) is an Incredible Growth Stock: 3 Reasons Why
Halozyme Therapeutics (HALO) could produce exceptional returns because of its solid growth attributes.
- Zacks
Halozyme Therapeutics (HALO) Upgraded to Buy: Here's What You Should Know
Halozyme Therapeutics (HALO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
© 2024 Yahoo. All rights reserved.